GO:1902462 positive regulation of mesenchymal stem cell proliferation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902462 describes any process that activates or increases the frequency, rate or extent of mesenchymal stem cell (MSC) proliferation.
• MSC proliferation is positively regulated by Hippo pathway inactivation, Akt/β-catenin signaling, autophagy modulation, and paracrine factors from exosomes.
• Key genes and proteins include YAP/TAZ, AKT1, CTNNB1 (β-catenin), PRX1, and PD-L1, which influence MSC self-renewal and differentiation.
• Dysregulated MSC proliferation contributes to ovarian insufficiency, radiation enteritis, lung cancer progression, and ectopic bone formation in ankylosing spondylitis.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of MSC proliferation regulators.
• EDITGENE provides end-to-end CRISPR cell model services and library screening to accelerate MSC biology research.
Description
Mesenchymal stem cells (MSCs) are multipotent stromal cells that self-renew and differentiate into osteoblasts, chondrocytes, and adipocytes. The biological process defined by GO:1902462, positive regulation of mesenchymal stem cell proliferation, encompasses all molecular events that stimulate MSC expansion. This process is essential for tissue homeostasis, regeneration, and repair, and its dysregulation underlies numerous pathologies including premature ovarian insufficiency, radiation-induced tissue damage, and cancer progression. Understanding the positive regulators of MSC proliferation provides mechanistic insight into regenerative medicine and disease pathogenesis. Recent studies have identified diverse signaling axes, such as Hippo/YAP, Akt/β-catenin, and autophagy, that converge to control MSC proliferation. These findings highlight the therapeutic potential of targeting MSC proliferation for treating degenerative conditions and improving stem cell-based therapies. This article synthesizes current knowledge on GO:1902462, covering its definition, mechanisms, key genes, disease relevance, and research methodologies including CRISPR-based approaches.
positive regulation of mesenchymal stem cell proliferation At A Glance
| GO ID | GO:1902462 |
|---|---|
| GO term | positive regulation of mesenchymal stem cell proliferation |
| Ontology | biological_process |
| Synonym | activation of mesenchymal stem cell proliferation; activation of MSC proliferation; positive regulation of MSC proliferation; up regulation of mesenchymal stem cell proliferation; up-regulation of mesenchymal stem cell proliferation; upregulation of mesenchymal stem cell proliferation; up regulation of MSC proliferation; up-regulation of MSC proliferation; upregulation of MSC proliferation |
| Major function | Stimulation of MSC self-renewal and expansion for tissue regeneration and repair |
| Related pathways | Hippo signaling, Akt/β-catenin signaling, autophagy, exosome-mediated paracrine signaling |
| Disease relevance | Premature ovarian insufficiency, radiation enteritis, lung cancer, ankylosing spondylitis |
| Research methods | CRISPR knockout/knock-in, RNA-seq, single-cell RNA-seq, exosome treatment, autophagy assays |
What Is GO:1902462?
GO:1902462 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of mesenchymal stem cell proliferation. In other words, it includes all molecular signals, pathways, and cellular events that promote the division and expansion of MSCs, whether through growth factor stimulation, inhibition of anti-proliferative signals, or modulation of cell cycle machinery.
Why Is positive regulation of mesenchymal stem cell proliferation Important in Cell Biology?
Positive regulation of MSC proliferation is critical for maintaining tissue homeostasis and enabling regenerative responses after injury. MSCs are widely used in cell therapy, and their expansion capacity directly affects therapeutic efficacy. Dysregulated MSC proliferation contributes to diseases such as premature ovarian insufficiency, radiation enteritis, and cancer progression. Therefore, understanding the molecular mechanisms that positively regulate MSC proliferation is essential for developing targeted interventions in regenerative medicine and oncology.
• Enables MSC expansion for cell-based therapies in regenerative medicine.
• Hippo pathway inactivation promotes MSC proliferation and improves ovarian function in premature ovarian insufficiency.
• Autophagy modulates MSC proliferation and differentiation into neurons.
• Exosomal miR-195 from MSCs regulates Akt/β-catenin pathway to support intestinal stem cell proliferation.
• PD-L1+ MSCs exhibit enhanced immunomodulatory capacity and influence ectopic bone formation in ankylosing spondylitis.
• PRX1-positive MSCs drive molar morphogenesis, linking proliferation to developmental processes.
• Immunologically activated MSCs inhibit lung cancer cell growth and metastasis.
• Leydig cell stem cells share proliferative mechanisms with MSCs.
• MSC-derived exosomes are effective for radiation enteritis by promoting epithelial stem cell proliferation.
• Dysregulated MSC proliferation can lead to ectopic bone formation and fibrosis.
What Happens During positive regulation of mesenchymal stem cell proliferation?
Initiation by Growth Factors and Exosomes
In simple terms: External signals like growth factors or exosomes tell MSCs to start dividing.
Positive regulation of MSC proliferation is often initiated by extracellular cues such as growth factors, cytokines, or exosomes. For example, human umbilical cord MSC-derived exosomes improve ovarian function and proliferation in premature ovarian insufficiency by regulating the Hippo signaling pathway. Similarly, MSC-derived exosomes regulate miR-195/Akt/β-catenin pathway to promote proliferation of intestinal epithelial stem cells. These exosomal signals deliver miRNAs and proteins that activate intracellular cascades, leading to MSC expansion.
Intracellular Signaling Cascades
In simple terms: Inside the cell, a relay of proteins passes the message to the nucleus.
Once activated, signaling cascades such as Hippo, Akt, and β-catenin transmit proliferative signals. Inactivation of Hippo pathway components (e.g., YAP/TAZ) leads to nuclear translocation of YAP/TAZ, which drives expression of proliferation-associated genes. The Akt/β-catenin pathway is also crucial; exosomal miR-195 regulates this axis to enhance proliferation. Autophagy plays a modulatory role, as its manipulation affects MSC proliferation and differentiation into neurons.
Cell Cycle Entry and Progression
In simple terms: The cell cycle machinery is switched on, pushing MSCs to divide.
Positive regulators ultimately converge on cell cycle machinery, promoting G1/S transition and DNA replication. Key cyclins and CDKs are upregulated, while cell cycle inhibitors are suppressed. This leads to increased frequency and rate of MSC proliferation. Studies on Leydig cell stem cells, which share properties with MSCs, highlight the importance of proliferation for maintaining stem cell pools.
Integration with Differentiation and Tissue Context
In simple terms: Proliferation is balanced with differentiation to meet tissue needs.
MSC proliferation is tightly coordinated with differentiation. For instance, PRX1-positive MSCs drive molar morphogenesis, where proliferation and differentiation are spatially and temporally regulated. In ankylosing spondylitis, PD-L1+ MSCs show enhanced immunomodulatory capacity and alleviated ectopic new bone formation, linking proliferation to pathological bone formation. Immunologically activated MSCs can inhibit lung cancer cell growth and metastasis, demonstrating context-dependent effects.
Key Genes Involved in GO:1902462 positive regulation of mesenchymal stem cell proliferation
The following genes and proteins are key players in the positive regulation of mesenchymal stem cell proliferation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| YAP1 | Hippo pathway effector; promotes MSC proliferation when nuclear | Target for ovarian insufficiency and regeneration |
| TAZ (WWTR1) | Hippo pathway effector; co-activator of proliferation genes | Studied in MSC expansion and differentiation |
| AKT1 | Serine/threonine kinase; activates pro-survival and proliferative signals | Central to exosome-mediated MSC proliferation |
| CTNNB1 (β-catenin) | Wnt signaling mediator; drives cell cycle progression | Regulated by miR-195 in MSC exosome effects |
| PRX1 (PRRX1) | Transcription factor; regulates MSC proliferation in craniofacial development | Molar morphogenesis model |
| PD-L1 (CD274) | Immune checkpoint; marks immunomodulatory MSCs | Ankylosing spondylitis and ectopic bone formation |
| ATG5 | Autophagy-related; modulates MSC proliferation and neuronal differentiation | Autophagy studies in bone marrow MSCs |
| BECN1 | Autophagy regulator; influences MSC survival and proliferation | Autophagy pathway |
| MAP1LC3B | Autophagosome marker; reflects autophagic flux | MSC differentiation into neurons |
| CDK4 | Cyclin-dependent kinase; promotes G1/S transition | General cell cycle control in MSCs |
| CCND1 | Cyclin D1; regulates G1 progression | MSC proliferation assays |
| MYC | Transcription factor; drives proliferation and growth | MSC expansion |
| LGR5 | Stem cell marker; intestinal epithelial stem cell proliferation | Radiation enteritis model |
| MIR195 | MicroRNA; regulates Akt/β-catenin pathway | Exosome-mediated MSC effects |
| SOX9 | Transcription factor; chondrogenic differentiation | MSC lineage commitment |
| RUNX2 | Transcription factor; osteogenic differentiation | MSC differentiation balance |
| PPARG | Transcription factor; adipogenic differentiation | MSC differentiation balance |
How Is positive regulation of mesenchymal stem cell proliferation Regulated?
Positive regulation of MSC proliferation is controlled by multiple signaling pathways. The Hippo pathway acts as a brake; its inactivation allows YAP/TAZ to enter the nucleus and promote proliferation. The Akt/β-catenin pathway is activated by exosomal miR-195, enhancing proliferation. Autophagy modulates MSC proliferation, with autophagy-related genes affecting the balance between proliferation and differentiation. Additionally, immune activation can alter MSC proliferative capacity, as seen with PD-L1+ MSCs in ankylosing spondylitis.
positive regulation of mesenchymal stem cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| YAP1 | Premature ovarian insufficiency | MSC exosome treatment in mouse model |
| AKT1 | Radiation enteritis | Intestinal epithelial stem cell co-culture |
| PD-L1 | Ankylosing spondylitis | Single-cell RNA-seq of patient MSCs |
| PRX1 | Molar morphogenesis | Mouse incisor development model |
| ATG5 | Neurodegeneration | MSC differentiation into neurons |
Premature Ovarian Insufficiency
Human umbilical cord MSC-derived exosomes improve ovarian function and proliferation in premature ovarian insufficiency by regulating the Hippo signaling pathway. This suggests that enhancing MSC proliferation via Hippo inactivation could be therapeutic.
Radiation Enteritis
MSC-derived exosomes are effective for radiation enteritis and are essential for the proliferation and differentiation of Lgr5+ intestinal epithelial stem cells by regulating the miR-195/Akt/β-catenin pathway. This highlights the role of MSC paracrine factors in promoting stem cell proliferation.
Lung Cancer
Immunologically activated MSCs inhibit lung cancer cell growth and metastasis. This indicates that MSC proliferation status and immune activation can influence tumor progression, with potential therapeutic implications.
Ankylosing Spondylitis
Single-cell RNA sequencing identified PD-L1+ MSCs with enhanced immunomodulatory capacity that alleviated ectopic new bone formation in ankylosing spondylitis. Dysregulated MSC proliferation may contribute to pathological bone formation.
From positive regulation of mesenchymal stem cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote MSC proliferation? | CRISPR knockout in primary MSCs or MSC lines |
| Does a point mutation in gene X affect MSC proliferation? | CRISPR point mutation knock-in |
| Does overexpression of gene X enhance MSC proliferation? | Lentiviral overexpression in MSCs |
| Does a tagged version of gene X localize to specific compartments? | CRISPR tagged knock-in |
| Which genes regulate MSC proliferation in a genome-wide manner? | CRISPR library screening |
| What is the transcriptomic profile of proliferating MSCs? | RNA-seq and single-cell RNA-seq |
How to Study the positive regulation of mesenchymal stem cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on MSC proliferation | Identify essential genes |
| CRISPR knock-in | Precise mutation or tag introduction | Model disease variants or track proteins |
| Exosome treatment | Paracrine effects on proliferation | Ovarian insufficiency, radiation enteritis |
| Single-cell RNA-seq | Heterogeneity of MSC subpopulations | Discover PD-L1+ MSCs |
| Autophagy assays | Autophagic flux and related gene expression | MSC differentiation into neurons |
| RNA-seq | Transcriptomic changes during proliferation | Pathway discovery |
| CRISPR library screening | Genome-wide identification of regulators | Unbiased discovery of proliferation modulators |
| Immunohistochemistry | Protein expression and localization in tissues | Molar morphogenesis |
CRISPR Knockout and Knock-in
CRISPR/Cas9-mediated knockout of candidate genes in MSCs allows assessment of loss-of-function effects on proliferation. Knock-in of point mutations or tags enables precise modeling of disease variants or tracking of proteins. These approaches are essential for causal inference.
Exosome Isolation and Treatment
MSC-derived exosomes can be isolated and applied to target cells to study paracrine regulation of proliferation. This method has been used to demonstrate Hippo pathway regulation in ovarian insufficiency and miR-195/Akt/β-catenin signaling in radiation enteritis.
Single-Cell RNA Sequencing
Single-cell RNA-seq identifies heterogeneous MSC subpopulations with distinct proliferative capacities. It was used to discover PD-L1+ MSCs in ankylosing spondylitis.
Autophagy Assays
Autophagy flux can be monitored using LC3B puncta, ATG5/Beclin-1 expression, and electron microscopy. Autophagy modulation affects MSC proliferation and differentiation into neurons.
How CRISPR Can Be Used to Study GO:1902462 positive regulation of mesenchymal stem cell proliferation
Knockout
CRISPR knockout of candidate positive regulators (e.g., YAP1, AKT1) in MSCs can confirm their necessity for proliferation. This approach is widely used to dissect signaling pathways.
Point Mutation
Introducing specific point mutations (e.g., in CTNNB1 or AKT1) allows modeling of disease-associated variants and testing their impact on MSC proliferation. This provides insights into mechanism and potential drug targets.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP, FLAG) enables live-cell imaging and protein interaction studies. Tagged knock-in of YAP1 or β-catenin can reveal dynamic localization during proliferation.
Overexpression
Overexpression of positive regulators (e.g., PRX1, PD-L1) in MSCs can enhance proliferation and immunomodulatory capacity. This is useful for generating therapeutic MSC lines.
How EDITGENE Supports positive regulation of mesenchymal stem cell proliferation Research
Researchers studying positive regulation of mesenchymal stem cell proliferation-related genes often need to determine whether a candidate gene is causally involved in MSC expansion, differentiation, or disease. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of mesenchymal stem cell proliferation research.
Frequently Asked Questions About positive regulation of mesenchymal stem cell proliferation
What is GO:1902462?
GO:1902462 is a Gene Ontology biological process term for any process that activates or increases the frequency, rate or extent of mesenchymal stem cell proliferation.
What genes are involved in positive regulation of mesenchymal stem cell proliferation?
Key genes include YAP1, TAZ, AKT1, CTNNB1, PRX1, PD-L1, and autophagy-related genes like ATG5.
How is MSC proliferation regulated?
MSC proliferation is positively regulated by Hippo pathway inactivation, Akt/β-catenin signaling, exosomal miRNAs, and autophagy modulation.
What diseases are associated with dysregulated MSC proliferation?
Premature ovarian insufficiency, radiation enteritis, lung cancer, and ankylosing spondylitis are linked to altered MSC proliferation.
What methods are used to study MSC proliferation?
CRISPR knockout/knock-in, exosome treatment, single-cell RNA-seq, autophagy assays, and RNA-seq are commonly used.
How do exosomes affect MSC proliferation?
MSC-derived exosomes deliver miRNAs and proteins that regulate pathways like Hippo and Akt/β-catenin to promote proliferation.
What is the role of autophagy in MSC proliferation?
Autophagy modulates MSC proliferation and differentiation, with autophagy-related genes affecting these processes.
Can CRISPR be used to study MSC proliferation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of gene function in MSC proliferation.
What is the Hippo pathway's role in MSC proliferation?
Hippo pathway inactivation leads to YAP/TAZ nuclear translocation, which promotes MSC proliferation.
How does PD-L1 relate to MSC proliferation?
PD-L1+ MSCs have enhanced immunomodulatory capacity and are associated with alleviated ectopic bone formation in ankylosing spondylitis.
Conclusion
GO:1902462, positive regulation of mesenchymal stem cell proliferation, is a critical biological process with broad implications for regenerative medicine and disease. Key signaling pathways such as Hippo, Akt/β-catenin, and autophagy converge to control MSC expansion. Dysregulation of this process contributes to ovarian insufficiency, radiation enteritis, cancer, and ectopic bone formation. CRISPR-based models and advanced screening technologies are indispensable for dissecting these mechanisms. EDITGENE offers comprehensive services to support researchers in this field, from knockout and knock-in cell models to library screening and bioinformatics.
References
- 1. Li Z et al.. 2021. Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Improve Ovarian Function and Proliferation of Premature Ovarian Insufficiency by Regulating the Hippo Signaling Pathway.. Front Endocrinol (Lausanne) 12:711902 PMID: 34456868
- 3. Ye H et al.. 2023. Inhibitory Effect of Immunologically Activated Mesenchymal Stem Cells on Lung Cancer Cell Growth and Metastasis.. Cancer Biother Radiopharm 38(5):322-335 PMID: 33769841
- 4. Li B et al.. 2016. Role of autophagy on bone marrow mesenchymal stem‑cell proliferation and differentiation into neurons.. Mol Med Rep 13(2):1413-9 PMID: 26676567
- 5. Luo X et al.. 2025. Single-cell RNA sequencing identifies PD-L1 + mesenchymal stem cells with enhanced immunomodulatory capacity and alleviated the degree of ectopic new bone formation in ankylosing spondylitis.. Stem Cell Res Ther 16(1):684 PMID: 41462465
- 6. Xu X et al.. 2024. PRX1-positive mesenchymal stem cells drive molar morphogenesis.. Int J Oral Sci 16(1):15 PMID: 38369512
- 7. Yang L et al.. 2023. Mesenchymal Stem Cell-Derived Exosomes are Effective for Radiation Enteritis and Essential for the Proliferation and Differentiation of Lgr5(+) Intestinal Epithelial Stem Cells by Regulating Mir-195/Akt/β-Catenin Pathway.. Tissue Eng Regen Med 20(5):739-751 PMID: 37326937
- 8. Chen H et al.. 2017. Leydig cell stem cells: Identification, proliferation and differentiation.. Mol Cell Endocrinol 445:65-73 PMID: 27743991
